USP 175865-59-5 iValganciclovir hydrochloride ye-Antiviral
| Imvelisoigama | Valgancyclovir hydrochloride |
| Izithethantonye | L-Valine,2-[(2-aMino-1,6-dihydro-6-oxo-9H-purin-9-yl)Methoxy]-3-hydroxypropylester,hydrochloride(1:1);2-[(2-- amino-6-oxo-6,9-dihydro-3H-purin-9-yl)methoxy]-3-hydroxypropyl(2S)-2-amino-3-methylbutanoatehydChemicalbookrochloridehydrate;L-Valine,2-[(2-amino- 1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropylester,monohydrochloridehydrate |
| Inombolo yeCAS. | 175865-59-5 |
| Imbonakalo | I-crystalline powder emhlophe okanye emhlophe |
| Ifomula yeemolekyuli | C14H22N6O5.HCl |
| Ubunzima beMolekyuli | 390.83 |
| Ukusetyenziswa | IBanga lezamayeza okanye injongo yoPhando |
| Ukupakisha | Ngokwesicelo sakho |
| Ugcino | Londoloza kwizikhongozeli eziqinile, ezikwaziyo ukumelana nokukhanya kwindawo epholileyo |
| Valgancyclovir hydrochloride Cas:175865-59-5 | ||
| Izinto | Umgangatho | Iziphumo |
| Imbonakalo | I-crystalline powder emhlophe okanye emhlophe | umgubo omhlophe |
| Ukuchongwa | I-Infrared Absorption: Ihambelana naleyo yomgangatho wereferensiUkufunxwa kwe-Ultraviolet: Ihambelana naleyo yomgangatho wereferensiIsisombululo emanzini (1 kuma-20) siyahlangabezana neemfuno zovavanyo lweChloride | Iyahambelana Iyahambelana
Iyahambelana |
| Isopropyl utywala | ≤1.0% | 0.13% |
| Amanzi | ≤8.0% | 4.5% |
| Iintsimbi ezinzima | ≤20ppm | Iyahambelana |
| Pd | ≤10ppm | ＜10ppm |
| Intsalela ekutshisweni | ≤0.1% | 0.02% |
| Ukungcola okunxulumeneyo | IValganciclovir:IGanciclovir: ≤1.5%IGuanine: ≤1.5% I-Methoxymethylguanine: ≤0.3% Isovalganciclovir: ≤0.5% I-Monoacetoxyganciclovir: ≤0.15% I-Bis-valine easter ye-ganciclovir: ≤0.1% I-Homologue ye-valganciclovir: ≤0.25% Imp H: ≤0.1% Imp I: ≤0.1% I-Ganciclovir monopropionate: ≤0.15% I-Valganciclovir dimer (stereoisomer A): ≤0.1% I-Valganciclovir dimer (stereoisomer B): ≤0.1% I-Valganciclovir dimer (stereoisomer C): ≤0.1% Okunye ukungcola okuchongiweyo okukodwa: ≤0.1% Iyonke enye ukungcola okuchongiweyo: ≤0.1% I-Ganciclovir mono-N-methyl valinate (Uvavanyo 2):≤0.3% Ukungcola okukodwa okungachazwanga (Uvavanyo lwe-1 kunye ne-2): ≤0.1 % Ukungcola okungachazwanga ngokupheleleyo (Uvavanyo lwe-1 kunye ne-2): ≤0.25% Ukungcola okupheleleyo (Uvavanyo lwe-1 kunye noVavanyo lwe-2): ≤3.0 | /0.02%0.01% 0.03% 0.02% ND 0.04% 0.01% 0.01% 0.004% ND ND ND ND Ubukhulu 0.04% 0.04%
0.02% Ubuninzi 0.02% 0.13% 0.78% |
| Diastereomer umlinganiselo | 45:55 ukuya ku-55:45 | 54:46 |
| Ukucoceka kwe-Enantiomeric ye-valganciclovir | ≥97.0% | 99.9% |
| Uvavanyo lweHPLC | 97.0%～102.0% | 98.8% |
| Isiphelo: ihambelana ne-USP40. | ||
Ulwazi lweNkampani
√ Amava apheleleyo omaleko wolawulo kumzi-mveliso kunye namagcisa anezakhono abalandeli; √ Umgangatho usoloko uyingqwalasela yethu ephezulu, inkqubo yeQC eQinisekileyo; √ Iminyaka eli-11 yamava eqela lokuthengisa kumazwe angaphandle; √ ilebhu yeR&D eZimeleyo; √ Iindibano zocweyo zeGMP ezimbini ezityikityiweyo zexesha elide; √ Imithombo etyebileyo yeefektri ezininzi ezingasebenziyo ukulungiselela iprojekthi elungelelanisiweyo; √ Iqela elisebenzayo eliSebenzayo ngokuSebenzayo ngendlela engaguqukiyo.
